Millennium Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Other funds holding KROS
NCM
O
MAP
Millennium Management's KROS Position: Q2 2026 in Review
Millennium Management increased its Keros Therapeutics (KROS) stake by 73% in Q2 2026, buying an estimated $868K and bringing the position to 184,822 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3830.
Millennium Management first reported a position in KROS in Q3 2020 and has held it in 22 quarters since. The position peaked at $33.3M in Q3 2024. 132 funds tracked by Wall St. Rank hold KROS as of Q2 2026.
- Millennium Management held 184,822 shares of Keros Therapeutics worth $1.98M as of Q2 2026.
- Millennium Management bought 77,964 Keros Therapeutics shares in Q2 2026, an estimated $868K.
- Keros Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3830 holding.
- Millennium Management first reported a position in Keros Therapeutics in Q3 2020 and has held it in 22 quarters since.
- Millennium Management's Keros Therapeutics position peaked at $33.3M in Q3 2024.
- 132 funds tracked by Wall St. Rank held Keros Therapeutics as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.